Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024

Li Watsek Reiterated (ASND) at Buy and Held Target at $173 on, Apr 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-173-on-apr-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $173 on, Apr 1st, 2024.

Li has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 0 agree with Li's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Li


  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $260 on, Friday, March 15th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $150 on, Wednesday, December 20th, 2023

Publication Contributing Sources